Interleukin 2 (IL-2) is the major growth factor for T lymphocytes and plays a critical role in the regulation of specific immune responses. IL-2 initiates its biological response by specifically binding to its glycoprotein receptor (lL-2R). Recent studies have demonstrated that the functional IL-2R is a multicomponent complex of at least two and as many as four distinct subunits. These include the well characterized 55 kDa IL-2 binding alpha subunit, the 75 kDa IL-2 binding beta subunit, a 22 kDa gamma subunit that co-precipitates with the beta subunit. The latter two subunits have been just recently identified in our biochemical characterization of the mouse lL-2R and the human equivalents of these proteins have not yet been found. The major objectives of this proposal are to biochemically characterize these newly described beta, gamma and delta subunits and to establish the role of each subunit in the formation of a functional high affinity lL-2R complex. Binding studies of wild type and mutant mouse IL-2 will be used to characterize the ligand-binding properties of lL-2Rbeta and define the ligand contact sites of IL2R alpha and lL-2R beta. Biochemical studies will be performed for cell surface and metabolically labeled IL-2R subunits to more fully describe the biochemical properties of lL-2Rbeta, gamma and delta and to determine the cellular site of assembly of the lL-2R complex. These experiments will take advantage of our recently prepared monoclonal antibody that efficiently precipitates the lL-2R beta/gamma heterodimer. The role of each subunit in the formation of a functional lL-2R will be assessed by attempting to reconstitute functional lL-2R in non-lymphoid cells. These experiments will require the cDNA cloning and sequencing of each subunit and the subsequent expression of these cDNAs in non-lymphoid cells by transfection. Mutant cell lines will also be produced that express abnormal lL-2R to facilitate the identification and characterization of the assembly of the components required for the formation of functional lL-2R and to also assess the possibility that one or more of the three other lL-2R associated proteins, plOO, pl35 and pl8O, might be important for a functional lL-2R. These studies will provide information relating to the molecular mechanisms controlling high and low affinity ligand-binding and may provide clues into the mechanism of IL-2 signal transduction. This work will help define normal cellular growth control which is important for our understanding of abnormal, or malignant cell growth. Since IL-2 has been implicated in various T and B cell responses, these studies are also relevant to the basis by which an immune response is regulated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045957-06
Application #
3189230
Study Section
Experimental Immunology Study Section (EI)
Project Start
1987-06-01
Project End
1995-05-31
Budget Start
1992-07-22
Budget End
1993-05-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33146
Cheng, Guoyan; Yu, Aixin; Dee, Michael J et al. (2013) IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J Immunol 190:1567-75
Cheng, Guoyan; Yuan, Xiaomei; Tsai, Matthew S et al. (2012) IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J Immunol 189:1780-91
Yuan, Xiaomei; Malek, Thomas R (2012) Cellular and molecular determinants for the development of natural and induced regulatory T cells. Hum Immunol 73:773-82
Cheng, Guoyan; Yu, Aixin; Malek, Thomas R (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241:63-76
Malek, Thomas R; Castro, Iris (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33:153-65
Yu, Aixin; Zhu, Linjian; Altman, Norman H et al. (2009) A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30:204-17
Bayer, Allison L; Lee, Joon Youb; de la Barrera, Anabel et al. (2008) A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 181:225-34
Adeegbe, Dennis; Bayer, Allison L; Levy, Robert B et al. (2006) Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 176:7149-53
Yu, Aixin; Malek, Thomas R (2006) Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells. J Immunol 177:5115-21
Jin, Haoli; Carrio, Roberto; Yu, Aixin et al. (2004) Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 173:657-65

Showing the most recent 10 out of 20 publications